HIGHLIGHTS
- who: Laura Sellmer from the Discovery Institute, United States of Pittsburgh, United States have published the research: Markers of Immune Cell Exhaustion as Predictor of Survival in Surgically-Treated Early-Stage NSCLC, in the Journal: (JOURNAL)
- what: Since the patients in this study had early-stage NSCLC, it may be the case that their tumors had not yet developed the immunosuppressive environment that is typical of advanced tumors .
- how: This study was conducted in accordance with the Declaration of Helsinki. There is a potential for sampling bias because of the histological sections that . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.